Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Huawei Cai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1341-8417; OpenAlex author ID A5051190727. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. 64Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer. Last author DOI 10.1021/acs.molpharmaceut.4c01368↗
  2. Copper deprivation enhances the chemosensitivity of pancreatic cancer to rapamycin by mTORC1/2 inhibition. Co-author DOI 10.1016/j.cbi.2023.110546↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nengwen Ke · 2 shared papers, 2023–2025 · strength 0.38
  2. Ruiman Geng · 2 shared papers, 2023–2025 · strength 0.38
  3. Ruomeng Liu · 1 shared paper, 2025 · strength 0.24
  4. Li Zhao · 1 shared paper, 2025 · strength 0.24
  5. Ziyao Wang · 1 shared paper, 2023 · strength 0.14
  6. Xubao Liu · 1 shared paper, 2023 · strength 0.14
  7. Yu Mou · 1 shared paper, 2023 · strength 0.14
  8. Ji Liu · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.